INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE EVIDENCE INDEX

The Study Library.

8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.

People assigned to a diet, food or program and measured.

2,768 studies · page 15 of 116

2018 / Secondary analysis of two trials

Women following intermittent energy restriction showed spontaneous reductions in reported energy intake on unrestricted days.

Researchers analyzed self-reported food records from two trials of intermittent energy restriction (IER) in women (44 women for 6 months and 72 women for 4 months) to evaluate energy intake on unrestricted days. In both studies, reported energy intake on unrestricted days was 19% lower than the allocated isoenergetic diet, and 21% (Study 1) and 29% (Study 2) lower than baseline reported daily intakes, with similar reductions immediately before, after, and on other unrestricted days. Combined 3-month percentage weight loss was -5.8% (-6.7 to -4.7%) in those with consistent restriction days versus -7.4% (-8.7 to -6.2%) in the non-consistent group (p = .09). The authors noted that these findings need confirmation in larger groups, ideally using objective measures of energy balance.

Harvey J, Howell A, Morris J, et al. Food Sci Nutr, 2018. PMID 29876119

2018 / Randomized crossover trial

Small doses of fructose or allulose did not alter postprandial glucose in healthy adults.

A randomized crossover trial in 25 healthy adults assessed adding 0 g, 5 g, or 10 g of fructose or allulose to a 75-g oral glucose challenge. Neither sugar significantly changed plasma glucose incremental area under the curve or secondary glycemic markers. The authors noted the findings were limited by low statistical power stemming from greater than anticipated intra-individual variation.

Braunstein CR, Noronha JC, Glenn AJ, et al. Nutrients, 2018. PMID 29890724

2018 / Randomized crossover trial

Replacing milk with soymilk or calcium-fortified soymilk reduced postprandial serum phosphorus levels in healthy subjects.

Ten healthy subjects consumed three test meals containing milk, soymilk, or calcium-fortified soymilk with equal calcium to milk in a randomized crossover design. Blood was sampled up to 360 minutes and urine from 0 to 360 minutes post-meal. Serum phosphorus levels decreased the most after the soymilk meal and the least after the milk meal. Serum intact parathyroid hormone initially dropped and then gradually rose after each meal, with changes being more pronounced for soymilk than for milk or calcium-fortified soymilk.

Sakuma M, Suzuki A, Kikuchi M, et al. J Clin Biochem Nutr, 2018. PMID 29892166

2018 / Randomized controlled trial

Energy compensation was similar between 1,500 and 3,000 kcal/week of exercise, but 3,000 kcal/week was sufficient to decrease body fat.

Thirty-six overweight-to-obese sedentary adults were randomized to exercise expending 300 or 600 kcal/session, 5 days/week for 12 weeks (1,500 vs. 3,000 kcal/week). The 3,000 kcal/week group significantly decreased percentage and kilograms of body fat (P < 0.01), whereas the 1,500 kcal/week group did not. The 1,500 and 3,000 kcal/week groups compensated for 943 (95% CI: -164 to 2,050) and 1,007 (95% CI: 32 to 1,982) kcal/week (62.9% and 33.6% of exercise energy expenditure, respectively; P >= 0.93 between groups). Resting metabolic rate and energy intake did not change, while food reinforcement and glucagon-like peptide-1 decreased (P < 0.02) and acylated ghrelin increased (P <= 0.02).

Flack KD, Ufholz K, Johnson L, et al. Am J Physiol Regul Integr Comp Physiol, 2018. PMID 29897822

2018 / Multicenter randomized trial (reanalyzed after protocol deviations)

A Mediterranean diet supplemented with extra-virgin olive oil or nuts reduced major cardiovascular events in persons at high cardiovascular risk.

Participants at high cardiovascular risk were assigned to a Mediterranean diet with extra-virgin olive oil, a Mediterranean diet with mixed nuts, or a control diet advising reduced dietary fat. Over a median follow-up of 4.8 years, primary end-point events occurred in 96 participants (3.8%) in the olive oil group, 83 (3.4%) in the nuts group, and 109 (4.4%) in the control group. In adjusted intention-to-treat analyses, the hazard ratio was 0.69 (95% CI, 0.53 to 0.91) for the olive oil group and 0.72 (95% CI, 0.54 to 0.95) for the nuts group versus control. Following identified protocol deviations involving non-randomized assignments at some sites, reanalyses omitting 1,588 participants with known or suspected protocol departures yielded similar results.

NANO counterpoint →

Estruch R, Ros E, Salas-Salvadó J, et al. N Engl J Med, 2018. PMID 29897866

2018 / Controlled pilot trial

A 12-week ketogenic diet reduced fat mass and increased LDL cholesterol without affecting performance metrics in CrossFit trainees.

Twelve CrossFit trainees were divided into a ketogenic diet group (n = 7) or a normal-diet control group (n = 5) for 12 weeks while continuing their training. Blood beta-hydroxybutyrate levels were 2.8- to 9.5-fold higher in the ketogenic group, confirming nutritional ketosis. In the ketogenic group, DXA fat mass decreased by 12.4% (p = 0.053), vastus lateralis thickness decreased by ~8% (p = 0.065), and dual-leg lean mass decreased by 1.4% (p = 0.068), while LDL cholesterol increased by ~35% (p = 0.048). No significant between-group differences were found for total lean body mass, fasting glucose, HDL cholesterol, triglycerides, resting energy expenditure, 1-RM back squat, 400 m run times, or VO2peak.

Kephart WC, Pledge CD, Roberson PA, et al. Sports (Basel), 2018. PMID 29910305

2018 / Bioavailability study

Allicin bioavailability varies widely across different garlic supplements and foods.

In 13 human participants, allicin bioavailability or bioequivalence was measured across 13 garlic supplements and 9 garlic preparations using breath allyl methyl sulfide after ingestion. Enteric tablets showed 36% to 104% bioavailability, which fell to 22% to 57% with high-protein meals. Non-enteric tablets achieved 80% to 111%, while cooked garlic foods lacking alliinase activity still yielded unexpected bioavailability ranging from 16% to 66%.

Lawson LD, Hunsaker SM Nutrients, 2018. PMID 29937536

2018 / Crossover trial

Consumption of anthocyanin-rich purple potato for 14 days significantly reduced arterial stiffness measured by pulse wave velocity in healthy adults.

A study evaluated the effects of consuming 200 g/day of cooked anthocyanin-rich purple potato (Purple Majesty, 288 mg anthocyanins) versus a white potato with negligible anthocyanins for 14 days, separated by a 7-day washout period, in 14 healthy adults. Pulse wave velocity was significantly reduced (p = 0.001) following Purple Majesty consumption. No significant changes were observed in blood pressure, HDL, LDL, triglycerides, glucose, insulin, or C-reactive protein, and no changes occurred following white potato consumption.

Tsang C, Smail NF, Almoosawi S, et al. Plant Foods Hum Nutr, 2018. PMID 29947011

2018 / Intervention trial with matched historical controls

An 8-hour time-restricted feeding regimen reduced body weight, energy intake, and systolic blood pressure in obese adults compared to historical controls.

Obese participants (n = 23) adhered to an 8-h time-restricted feeding regimen (ad libitum feeding 10:00 to 18:00 h, water fasting 18:00 to 10:00 h) for 12 weeks, compared against 23 matched historical controls. Over 12 weeks, body weight decreased by -2.6% ± 0.5 and energy intake by -341 ± 53 kcal/d relative to controls (P < 0.05). Systolic blood pressure also fell (-7 ± 2 mm Hg vs controls, P < 0.05). Fat mass, lean mass, visceral fat mass, diastolic blood pressure, LDL cholesterol, HDL cholesterol, triglycerides, fasting glucose, fasting insulin, HOMA-IR, and homocysteine did not differ significantly between groups.

Gabel K, Hoddy KK, Haggerty N, et al. Nutr Healthy Aging, 2018. PMID 29951594

2018 / Crossover study (in human volunteers)

An antioxidant marinade reduced fecal lipid peroxidation markers from beef consumption in humans and limited carcinogenesis in rodents.

Researchers tested whether an antioxidant marinade on beef with various degrees of cooking could limit lipid peroxidation and carcinogenesis in rats, Min mice, and human volunteers in a crossover study. Fresh beef increased lipoperoxidation in humans, rats, and mice, and increased colon carcinogenesis in the rodents. Without adverse organoleptic effects, the marinade reduced peroxidation biomarkers in human feces, normalized them in rodent feces, and reduced mucin-depleted foci in rats and adenomas in female Min mice.

Martin OCB, Naud N, Taché S, et al. Cancer Prev Res (Phila), 2018. PMID 29954759

2018 / Randomized controlled trial

Ketogenic diet reduced fat mass but did not increase muscle during resistance training.

In an eight-week resistance training trial with caloric surplus, men consuming a ketogenic diet showed reduced fat mass (-0.8 kg, 95% CI -1.6 to -0.1) and visceral adipose tissue (-96.5 g, 95% CI -159.0 to -34.0). Neither total weight nor muscle mass increased significantly in the ketogenic group. Conversely, the non-ketogenic diet group gained both body weight (0.9 kg) and muscle mass (1.3 kg, 95% CI 0.5 to 2.2).

Vargas S, Romance R, Petro JL, et al. J Int Soc Sports Nutr, 2018. PMID 29986720

2018 / Randomized, placebo-controlled, double-blind parallel trial

In obese, insulin-resistant men, 12 weeks of nicotinamide riboside supplementation was safe but did not improve insulin sensitivity or glucose metabolism.

Forty sedentary, obese men aged 40-70 years were randomized to receive 12 weeks of nicotinamide riboside (NR, 1000 mg twice daily) or placebo. NR supplementation did not improve insulin sensitivity, endogenous glucose production, glucose disposal, or glucose oxidation. Furthermore, NR had no effect on resting energy expenditure, lipolysis, lipid oxidation, or body composition. No serious adverse events occurred and safety blood tests remained normal.

Dollerup OL, Christensen B, Svart M, et al. Am J Clin Nutr, 2018. PMID 29992272

2018 / Single-group prospective trial

A plant-based diet initiated during a two-week educational hospitalization was followed by low cumulative relapse rates in ulcerative colitis patients.

Sixty patients with mild ulcerative colitis or UC in remission received a plant-based diet (PBD) and dietary guidance during a two-week educational hospitalization. Over a median follow-up of 3 years 6 months, 8 cases relapsed, with cumulative relapse rates at 1, 2, 3, 4, and 5 years of 2%, 4%, 7%, 19%, and 19%, respectively. During hospitalization, 77% of patients experienced improvement such as disappearance or decrease of bloody stool. Both short- and long-term PBD scores remained higher than baseline.

Chiba M, Nakane K, Tsuji T, et al. Perm J, 2018. PMID 30005726

2018 / Prospective single-arm study

A 6-month ketogenic diet reduced gut microbiome alpha diversity and altered bacterial composition in children with refractory epilepsy.

Twenty children with refractory epilepsy were prospectively evaluated before and 6 months after starting a ketogenic diet. Following 6 months of therapy, 2 patients became seizure-free, 3 achieved a ≥ 90% reduction, 5 had a 50-89% reduction, and 10 had a < 50% reduction, with all 10 responders showing EEG improvements. Fecal microbial profiles demonstrated lower alpha diversity compared with baseline, along with significantly decreased Firmicutes and increased Bacteroidetes abundance. Non-responsive patients were found to have enrichment of Clostridiales, Ruminococcaceae, Rikenellaceae, Lachnospiraceae, and Alistipes.

Zhang Y, Zhou S, Zhou Y, et al. Epilepsy Res, 2018. PMID 30007242

2018 / Secondary analysis of a trial (before-and-after / paired analysis)

A defined plant-based diet for 4 weeks significantly reduced lipoprotein(a), other atherogenic lipoproteins, and inflammatory markers in overweight and obese adults.

In a secondary analysis of a trial, 31 overweight and obese adults with LDL cholesterol >100 mg/dL consumed a defined plant-based diet for 4 weeks. Significant reductions were observed for serum Lp(a) (-32.0 ± 52.3 nmol/L, P = 0.003), apolipoprotein B (-13.2 ± 18.3 mg/dL, P < 0.0005), LDL particles (-304.8 ± 363.0 nmol/L, P < 0.0005), and small-dense LDL cholesterol (-10.0 ± 9.2 mg/dL, P < 0.0005). Significant reductions were also seen in IL-6, total white blood cells, Lp-PLA2, hs-CRP, and fibrinogen (all P ≤ 0.004).

Najjar RS, Moore CE, Montgomery BD Clin Cardiol, 2018. PMID 30014498

2018 / Randomized, double-blind, placebo-controlled trial

Vitamin D supplementation did not improve overall survival in NSCLC patients, but improved 5-year survival in early-stage adenocarcinoma with low vitamin D.

A randomized, double-blind trial evaluated vitamin D supplements (1,200 IU/day) versus placebo for 1 year in 155 postoperative NSCLC patients followed for a median of 3.3 years. In the total population, no significant difference was observed for RFS or OS between groups. However, among patients with early-stage adenocarcinoma and low 25(OH)D (<20 ng/mL), vitamin D supplementation led to significantly higher 5-year RFS (86% vs. 50%, P = 0.04) and OS (91% vs. 48%, P = 0.02). DBP1 TT and CDX2 AA/AG genotypes were also markers of better prognosis.

Akiba T, Morikawa T, Odaka M, et al. Clin Cancer Res, 2018. PMID 30018118

2018 / Single-arm experimental feeding intervention

A high fruit and vegetable diet reduced the bone resorption marker CTX and increased the bone formation marker BAP in a 28-week feeding trial.

Twenty-nine participants underwent a 28-week single-arm feeding trial consisting of a 6-week low-fruit and vegetable diet (depletion-1), an 8-week high-fruit and vegetable diet, a second 6-week depletion, and an 8-week return to usual diet. Compared to baseline, depletion-1 increased serum CTX (from 0.68 to 0.97 ng/ml) and decreased BAP (from 10.7 to 9.5 µg/l; P<0.05). The high-fruit and vegetable diet subsequently reduced CTX to 0.60 ng/ml and increased BAP to 11.3 µg/l compared to depletion-1 (P<0.05).

Cao JJ, Whigham LD, Jahns L Br J Nutr, 2018. PMID 30022739

2018 / Parallel randomized controlled trial

Multiple cold-water immersions attenuated muscle damage markers but did not alter systemic inflammation or muscle function recovery in active males.

Thirty physically active males with exercise-induced muscle damage were randomized to either a control group (n=15) or a cold-water immersion (CWI) group (n=15) receiving 20-minute immersions at 10 °C post-exercise and every 24 h for 72 h. No significant time × group interactions were found for muscle strength, vertical jump height recovery, or MMP-2 activity (p > 0.05). Muscle thickness returned to baseline at 24 h and was lower in the CWI group than control (p = 0.04). DOMS returned to baseline at 168 h in the CWI group (p = 0.109) but not control (p = 0.008), and creatine kinase at 168 h showed a greater peak for the control group (p = 0.016).

Siqueira AF, Vieira A, Bottaro M, et al. Sci Rep, 2018. PMID 30026562

2018 / Cross-sectional single-blind before-and-after study

Mechanical removal of tongue coating significantly increased the perceived intensity of salty taste.

This single-blind study evaluated whether removing tongue coating altered salt taste perception in 90 participants. Salt taste intensity was evaluated using a drop of prepared tomato soup on the dorsal tongue surface before and after mechanical tongue cleaning, measured via a general Labeled Magnitude Scale (gLMS). Mean salt taste intensity increased significantly after tongue cleaning compared to before (p = 0.0002).

Seerangaiyan K, Jüch F, Atefeh F, et al. J Nutr Health Aging, 2018. PMID 30080223

2018 / Randomized controlled trial

Baru almond consumption reduced waist circumference and increased HDL in overweight and obese women.

A trial randomized 46 overweight and obese women to an isoenergetic diet either supplemented with or free of baru almonds for 8 weeks. Compared with the control diet, consuming baru almonds reduced waist circumference by 2.45 cm (95% CI, -3.90 to -0.23; P = 0.03) and cholesteryl ester transfer protein expression by 0.23 mcg/mL (95% CI, -1.24 to -0.08; P = 0.03). High-density lipoprotein concentrations also increased by 4.82 mg/dL (95% CI, 0.03 to 8.88; P = 0.04).

de Souza RGM, Gomes AC, de Castro IA, et al. Nutrition, 2018. PMID 30086484

2018 / Randomized 3x3 crossover trial

Adding Hass avocado to a meal lowered 3-hour GLP-1 AUC compared to control in overweight adults, while gut hormones correlated with appetite scores.

A randomized 3x3 crossover study in 26 healthy overweight adults evaluated gut hormone responses and appetite sensations across three lunch test meals consumed one week apart: control, isoenergic avocado inclusive, and energy increased avocado added (AA). A decrease in the 3-hour GLP-1 area under the curve was observed with the AA meal compared to the control meal (P = 0.03). Across meals, PYY3-36 and GIP were negatively associated with hunger, desire, and amount to eat, and positively associated with fullness, satisfaction, and composite visual analog scale (VAS) score (all P < 0.001). GLP-1 was negatively associated with hunger and positively associated with satisfaction and composite VAS score (all P < 0.05).

Haddad E, Wien M, Oda K, et al. Eat Behav, 2018. PMID 30096700

2018 / Phase 1 placebo-controlled study and observational analyses

In a phase 1 study, oral nicotinamide boosted circulating NAD+ metabolites, was well tolerated, and was associated with less acute kidney injury.

In critically ill patients, an elevated urinary quinolinate/tryptophan ratio predicted acute kidney injury (AKI) and other adverse outcomes. A phase 1 placebo-controlled study of oral nicotinamide (NAM) demonstrated a dose-related increase in circulating NAD+ metabolites. Oral NAM was well tolerated and was associated with less AKI. The study also examined murine models of AKI.

Poyan Mehr A, Tran MT, Ralto KM, et al. Nat Med, 2018. PMID 30127395

2018 / Double-blinded randomized controlled crossover trial

Oral taurine supplementation (2 g/day) reduced the frequency, duration, and severity of muscle cramps in patients with chronic liver disease.

In a double-blind, randomized crossover trial, patients with chronic liver disease and frequent muscle cramps received either oral taurine or placebo for 4 weeks before crossing over. Out of 49 enrolled patients, 30 completed the protocol and were included in the final analysis. Compared to placebo, supplementation with 2 g taurine/day led to fewer cramps (7 fewer/fortnight, P = 0.03), reduced duration (89 minutes less/fortnight, P = 0.03), and reduced severity (1.4 units less on a Likert scale, P < 0.004). Oral taurine significantly increased serum taurine levels (P < 0.001) without adverse side effects.

Vidot H, Cvejic E, Carey S, et al. Aliment Pharmacol Ther, 2018. PMID 30136291

2018 / Randomized controlled trial

One night of sleep loss was accompanied by tissue-specific changes in DNA methylation, transcriptomics, and metabolism in human adipose tissue and muscle.

Researchers analyzed adipose tissue and skeletal muscle obtained from humans after one night of sleep loss and after one full night of sleep. Acute sleep loss was found to alter genome-wide DNA methylation in adipose tissue, along with tissue-specific transcriptomic, protein, and metabolite changes partially reflected in blood. Inflammation signatures were observed in both tissues, whereas circadian clock alterations were detected only in skeletal muscle alongside molecular signatures suggestive of muscle breakdown contrasting with an anabolic adipose tissue signature.

Cedernaes J, Schönke M, Westholm JO, et al. Sci Adv, 2018. PMID 30140739